Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25491692 |
US |
67 | 2 |
Intervertebral disc protrusion, Osteoarthritis, Muscle spasms, Back pain, Illness, Limb discomfort, Nerve oedema, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
2 | 25491731 |
US |
55 | 1 |
Hospitalisation, Skin disorder, Illness, |
||||
RISANKIZUMAB-RZAA, |
||||
3 | 25491895 |
US |
47 | 2 |
Illness, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
4 | 25491911 |
US |
64 | 2 |
Osteopenia, Mouth ulceration, Illness, Herpes zoster, |
||||
SARILUMAB, ATENOLOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
5 | 25492016 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
6 | 25492040 |
US |
44 | 1 |
Illness, Pneumonia, Pulmonary thrombosis, Sickle cell anaemia with crisis, |
||||
LENALIDOMIDE, FOLIC ACID, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
7 | 25492119 |
US |
2 | |
Illness, |
||||
BELIMUMAB, |
||||
8 | 25492370 |
US |
58 | 2 |
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, DRONEDARONE, EXEMESTANE, METHIMAZOLE, METOPROLOL TARTRATE, METOPROLOL, MONTELUKAST, |
||||
9 | 25492635 |
US |
75 | 2 |
Illness, Asthenia, Drug intolerance, |
||||
LENALIDOMIDE, |
||||
10 | 25492676 |
ES |
||
Diarrhoea, Illness, Pain, Decreased immune responsiveness, Blood cholesterol increased, Alopecia, Fatigue, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, ABEMACICLIB, ABEMACICLIB, EXEMESTANE, GOSERELIN, |
||||
11 | 25492747 |
US |
2 | |
Kidney infection, Device infusion issue, Somnolence, Inappropriate schedule of product administration, Memory impairment, Muscular weakness, Oropharyngeal pain, Infusion site mass, Migraine, Hypersensitivity, COVID-19, Illness, Wrong technique in product usage process, Abdominal discomfort, Malaise, Fatigue, |
||||
12 | 25493013 |
US |
2 | |
Herpes zoster meningoencephalitis, Meningitis viral, Illness, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
13 | 25493188 |
ES |
||
Large intestinal ulcer, Feeling abnormal, Illness, Flatulence, Discomfort, Abdominal pain, Malaise, Cognitive disorder, Nervousness, Weight increased, Swelling, Anxiety, Sleep disorder due to general medical condition, insomnia type, Breast inflammation, Functional gastrointestinal disorder, Dyschezia, Tumour marker increased, Memory impairment, Parosmia, Taste disorder, Abdominal pain upper, Dyspepsia, Diarrhoea, Diarrhoea, Fatigue, Nausea, Decreased appetite, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
14 | 25493527 |
CA |
65 | 2 |
Chills, Illness, Headache, Pain, Pyrexia, |
||||
ZOLEDRONIC ACID, |
||||
15 | 25493739 |
US |
||
Illness, Abdominal pain upper, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
16 | 25493774 |
US |
2 | |
Cerebrovascular accident, Illness, Product colour issue, Injection site pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
17 | 25494030 |
US |
1 | |
Product use issue, Illness, Weight increased, Depressed mood, Abdominal discomfort, Sinus disorder, Respiratory disorder, Rash pruritic, Malaise, Headache, Fatigue, Sinus congestion, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, FEXOFENADINE HYDROCHLORIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, FLUOXETINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LEVALBUTEROL TARTRATE, NALTREXONE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, MAGNESIUM CHLORIDE, GUAIFENESIN, |
||||
18 | 25494057 |
US |
83 | 2 |
Illness, |
||||
RIOCIGUAT, RIOCIGUAT, AMBRISENTAN, |
||||
19 | 25494181 |
US |
34 | 1 |
Impaired work ability, Illness, Loss of personal independence in daily activities, |
||||
PHENELZINE SULFATE, |
||||
20 | 25494197 |
US |
64 | 2 |
Illness, |
||||
TOFACITINIB, GABAPENTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, LEVOTHYROXINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
21 | 25494637 |
US |
2 | |
Cerebrovascular accident, Seizure, Gastric operation, Central nervous system lesion, Ulcer, Arthralgia, Illness, Impaired work ability, Skin disorder, |
||||
BELIMUMAB, |
||||
22 | 25494969 |
US |
2 | |
Illness, |
||||
LEVONORGESTREL, ETANERCEPT, |
||||
23 | 25495225 |
US |
35 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
24 | 25495401 |
US |
2 | |
Maternal exposure during pregnancy, Illness, |
||||
DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
25 | 25495414 |
32 | 2 | |
Cystitis interstitial, Condition aggravated, Illness, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
26 | 25495577 |
US |
1 | |
Illness, Drug ineffective, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROCHLOROTHIAZIDE, |
||||
27 | 25495760 |
US |
81 | 1 |
Pruritus, Dry skin, Illness, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
28 | 25495824 |
US |
69 | 2 |
Illness, Wrist surgery, |
||||
DUPILUMAB, DUPILUMAB, |
||||
29 | 25495950 |
US |
34 | 1 |
Illness, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
30 | 25495979 |
AR |
51 | 2 |
Asthmatic crisis, Rash, Injection site pain, Fear of injection, Illness, Food allergy, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
31 | 25495981 |
US |
2 | |
Drug ineffective, Illness, Product odour abnormal, Sinus disorder, Gastritis, Intestinal metaplasia, Feeling abnormal, Chromaturia, Renal pain, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
32 | 25499800 |
39 | 2 | |
COVID-19, General physical health deterioration, Suicidal ideation, Failure to thrive, Fatigue, Malaise, Dysphagia, Decreased appetite, Weight decreased, Dry mouth, Dysphonia, Anxiety, Heart rate increased, Insomnia, Malnutrition, Illness, Withdrawal syndrome, Panic attack, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, SERTRALINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
33 | 25491042 |
US |
2 | |
Illness, Product dose omission issue, |
||||
DUPILUMAB, THIAMINE HYDROCHLORIDE, ERGOCALCIFEROL, CARIPRAZINE, |
||||
34 | 25491051 |
US |
||
Illness, |
||||
INSULIN GLARGINE, |
||||
35 | 25491054 |
US |
26 | 2 |
Illness, Blood immunoglobulin E abnormal, |
||||
DUPILUMAB, |
||||
36 | 25491059 |
US |
59 | 2 |
Dizziness, Abdominal discomfort, Lethargy, Illness, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
37 | 25491101 |
US |
2 | |
Illness, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
38 | 25491181 |
US |
28 | 2 |
Illness, Product dose omission issue, |
||||
DUPILUMAB, |
||||
39 | 25491239 |
US |
3 | 2 |
Illness, Rebound eczema, |
||||
DUPILUMAB, |
||||
40 | 25491337 |
US |
73 | 1 |
Illness, |
||||
DUPILUMAB, |
||||
41 | 25491377 |
CA |
55 | 2 |
Rash, Decreased activity, Dysstasia, Gait disturbance, General physical health deterioration, Grip strength decreased, Illness, Inappropriate schedule of product administration, Influenza, Pain, Psoriatic arthropathy, Treatment failure, Condition aggravated, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, HYDROCORTISONE, DESOXIMETASONE, ADALIMUMAB, HYDROXYCHLOROQUINE, INFLIXIMAB, MELOXICAM, MELOXICAM, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE SULFATE, TRAMADOL HYDROCHLORIDE, PREDNISONE, INFLIXIMAB, SULFASALAZINE, ADALIMUMAB-ADAZ, |
||||
42 | 25491417 |
US |
2 | |
Illness, |
||||
43 | 25489984 |
US |
2 | |
Illness, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
44 | 25490042 |
US |
51 | 2 |
Rash macular, Illness, Stress, Neurodermatitis, Arthralgia, |
||||
DUPILUMAB, |
||||
45 | 25490076 |
CA |
59 | 2 |
Cardiac failure congestive, Arthralgia, International normalised ratio increased, Stress, Upper gastrointestinal haemorrhage, Illness, Pain, Drug intolerance, Platelet count decreased, Haemorrhage, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, ETANERCEPT, |
||||
46 | 25490174 |
US |
33 | 2 |
Hepatic enzyme increased, Blood glucose increased, Hypertension, Nausea, Sleep disorder, Weight decreased, Abdominal pain upper, Illness, Feeding disorder, |
||||
ROMOSOZUMAB-AQQG, |
||||
47 | 25490272 |
US |
||
Illness, Cough, |
||||
VIGABATRIN, |
||||
48 | 25490279 |
US |
1 | |
Illness, Cough, Pyrexia, |
||||
VIGABATRIN, |
||||
49 | 25490300 |
AU |
7 | 2 |
Viral infection, Illness, |
||||
DENOSUMAB, USTEKINUMAB, |
||||
50 | 25490875 |
US |
40 | 1 |
Illness, |
||||
51 | 25486522 |
US |
71 | 2 |
Device difficult to use, Product administration error, Wrong technique in product usage process, Illness, Blood cholesterol decreased, |
||||
EVOLOCUMAB, EVOLOCUMAB, ADALIMUMAB, |
||||
52 | 25486587 |
US |
85 | 1 |
Illness, Decreased appetite, Weight decreased, |
||||
LENALIDOMIDE, |
||||
53 | 25486791 |
US |
55 | 2 |
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, GLIMEPIRIDE, |
||||
54 | 25486807 |
US |
1 | |
Illness, |
||||
PIMAVANSERIN TARTRATE, |
||||
55 | 25486951 |
CA |
||
Condition aggravated, COVID-19, Influenza, Illness, Immune system disorder, Sinusitis, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CELECOXIB, DEXLANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
56 | 25487144 |
US |
||
Illness, |
||||
DULAGLUTIDE, |
||||
57 | 25487398 |
US |
75 | 2 |
Feeling abnormal, Illness, Pain, Asthenia, Gait disturbance, Abdominal discomfort, Hypersomnia, Vomiting, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, DONANEMAB-AZBT, MEMANTINE, MEMANTINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
58 | 25487581 |
CO |
1 | |
Death, Illness, Intentional dose omission, Therapy interrupted, Insurance issue, Malaise, Injection site mass, Injection site pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CALCIUM, |
||||
59 | 25487602 |
US |
1 | |
Illness, |
||||
RIVASTIGMINE, SACUBITRIL AND VALSARTAN, |
||||
60 | 25488013 |
DE |
46 | 2 |
Myocarditis, Hypoacusis, Tonsillitis, Illness, Urticaria papular, Dyspnoea, Rhinorrhoea, Arthralgia, Muscle spasms, Myalgia, Infection, |
||||
DENOSUMAB, |
||||
61 | 25488139 |
US |
2 | |
Illness, |
||||
TREPROSTINIL, TREPROSTINIL, HYDROXYCHLOROQUINE SULFATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FOLIC ACID, MELATONIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, BACLOFEN, TADALAFIL, KETAMINE HYDROCHLORIDE, ENOXAPARIN SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, BIOTIN, FLUTICASONE PROPIONATE, CLONIDINE, KETOPROFEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, GABAPENTIN, AMBRISENTAN, ONDANSETRON HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
62 | 25488316 |
GB |
2 | |
Illness, |
||||
TIRZEPATIDE, |
||||
63 | 25488321 |
US |
1 | |
Illness, |
||||
INSULIN GLARGINE, |
||||
64 | 25488330 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
65 | 25488360 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
66 | 25488363 |
US |
76 | 2 |
Illness, Feeding disorder, Malaise, Lethargy, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
67 | 25488635 |
US |
61 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
68 | 25488691 |
US |
61 | 2 |
Pneumonia, Intervertebral disc protrusion, Infusion related reaction, Nasopharyngitis, Ear infection, Product preparation error, Illness, Gastroenteritis viral, Hypoglycaemia, Pain, White blood cell count decreased, Back pain, Chills, Headache, Brain fog, Malaise, Pyrexia, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
69 | 25488700 |
US |
64 | 2 |
Illness, |
||||
TOFACITINIB, |
||||
70 | 25489167 |
US |
2 | |
Illness, |
||||
SARILUMAB, |
||||
71 | 25489199 |
US |
29 | 2 |
Oropharyngeal pain, Illness, |
||||
DUPILUMAB, |
||||
72 | 25489414 |
US |
65 | 2 |
Respiratory tract congestion, Secretion discharge, Illness, Nasopharyngitis, Drug ineffective, |
||||
DUPILUMAB, |
||||
73 | 25489852 |
US |
||
Illness, Drug ineffective, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
74 | 25490395 |
GB |
70 | 1 |
Illness, |
||||
INSULIN HUMAN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EZETIMIBE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RAMIPRIL, |
||||
75 | 25490445 |
US |
||
Death, Illness, |
||||
AXATILIMAB-CSFR, |
||||
76 | 25490515 |
US |
44 | 2 |
Illness, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
77 | 25490697 |
GB |
52 | |
Medication error, Illness, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
78 | 25490705 |
US |
79 | 1 |
Near death experience, Contraindicated product prescribed, Illness, Documented hypersensitivity to administered product, |
||||
ACETAMINOPHEN AND CODEINE, |
||||
79 | 25490721 |
US |
2 | |
Illness, Confusional state, Fear, Device power source issue, |
||||
TREPROSTINIL, TREPROSTINIL, ASPIRIN, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, AMIODARONE HYDROCHLORIDE, TORSEMIDE, |
||||
80 | 25490830 |
US |
||
Abdominal pain upper, Decreased appetite, Illness, |
||||
ACORAMIDIS HYDROCHLORIDE, |
||||
81 | 25493780 |
65 | 2 | |
Neck pain, Headache, Vomiting, Illness, Nausea, Dizziness, Taste disorder, Dysgeusia, |
||||
DENOSUMAB, LEVOTHYROXINE, ROSUVASTATIN, ERGOCALCIFEROL, CALCIUM, HYDROCORTISONE, |
||||
82 | 25481180 |
US |
2 | |
Feeding disorder, Illness, |
||||
ELUXADOLINE, |
||||
83 | 25481245 |
US |
48 | 1 |
Illness, Product dose omission issue, |
||||
AVAPRITINIB, |
||||
84 | 25481283 |
US |
2 | |
Myocardial infarction, Illness, Asthma, Nasopharyngitis, Hyperhidrosis, Platelet count increased, Nausea, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, OMALIZUMAB, FERROUS SULFATE, SEMAGLUTIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ALBUTEROL SULFATE, ALBUTEROL, HYDROXYUREA, ROPINIROLE, NITROGLYCERIN, EPINEPHRINE, LEVOTHYROXINE, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, GABAPENTIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ERGOCALCIFEROL, DICLOFENAC SODIUM, |
||||
85 | 25481326 |
US |
2 | |
Illness, Incorrect dose administered, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
86 | 25481463 |
CA |
2 | |
Root canal infection, Tooth abscess, Facial pain, Neck pain, COVID-19, Gastroenteritis, Illness, |
||||
UPADACITINIB, |
||||
87 | 25481479 |
US |
2 | |
Rheumatoid arthritis, Illness, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Needle issue, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, ERGOCALCIFEROL, FISH OIL, MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE HYDROCHLORIDE, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
88 | 25481599 |
US |
2 | |
Age-related macular degeneration, Pneumonia, Compression fracture, Benign renal neoplasm, Syncope, Illness, Limb injury, Gastrointestinal disorder, Blood glucose increased, Product storage error, |
||||
INSULIN DEGLUDEC, SEMAGLUTIDE, |
||||
89 | 25481707 |
US |
1 | |
Illness, |
||||
DOSTARLIMAB, |
||||
90 | 25481752 |
US |
2 | |
Illness, Product dose omission issue, |
||||
TROFINETIDE, |
||||
91 | 25481916 |
US |
44 | 1 |
Asthenia, Dizziness, Illness, Off label use, |
||||
LENALIDOMIDE, |
||||
92 | 25482001 |
DE |
1 | |
Death, Illness, Adverse event, |
||||
FINASTERIDE, |
||||
93 | 25482041 |
CA |
||
Illness, Poisoning, Fear of death, |
||||
94 | 25482078 |
BR |
79 | 2 |
Onychomycosis, Nail discomfort, Psoriasis, Urinary tract infection, Immunodeficiency, Fall, Upper limb fracture, Osteoporosis, Vitiligo, Psoriatic arthropathy, Back pain, Drug hypersensitivity, Illness, Skin exfoliation, |
||||
ADALIMUMAB, |
||||
95 | 25482090 |
US |
55 | 1 |
Intestinal resection, Illness, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
96 | 25482115 |
US |
||
Surgery, Illness, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
97 | 25482220 |
CA |
37 | 2 |
Illness, Influenza, Ear infection, Pneumonia, |
||||
ETANERCEPT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
98 | 25482320 |
CL |
8 | 1 |
Asphyxia, Illness, Productive cough, Discouragement, Irritability, Restlessness, Respiratory tract congestion, Lacrimation increased, Cough, Dyspnoea, Pyrexia, Vomiting, |
||||
IDURSULFASE, IDURSULFASE, IDURSULFASE, |
||||
99 | 25482348 |
US |
2 | |
Disability, Drug ineffective, Illness, Mental disorder, Injury, Gait disturbance, |
||||
UPADACITINIB, |
||||
100 | 25482453 |
US |
2 | |
Visual impairment, Illness, |
||||
MEPOLIZUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29